Pathophysiological considerations of seizures, epilepsy, and status epilepticus in the elderly

Aging and Disease

Volumn 2, Issue 4, 2011, Pages 278-285

  Verellen, Rebecca M ^a   Cavazos, Jose E ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Aging; Elderly; Epilepsy; Pathophysiology; Seizures; Status

Indexed keywords

EID: 84875266866     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Hauser WA (1992). Seizure disorders: the changes with age. Epilepsia, 33 (Suppl 4): 6-14.
2. Wallace H, Shorvon S, Tallis R (1998). Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rate of women with epilepsy. Lancet, 352:1790-3.
3. Leppik IE, Birnbaum AK (2009). Epilepsy in the elderly. Ann NY Acad Sci, 1184:208-24.
4. Hauser WA, Annegers JF, Kuland LT (1993). Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia, 34: 453-68.
5. Annegers JF, Hauser WA, Lee JR, Rocca WA (1995). Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia, 36: 327-33.
6. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D (1996). A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology, 46: 1029-35.
7. Cloyd J, Hauser W, Towne A, Ramsay R, Mattson R, Gilliam F, Walczak T (2006). Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Research, 68 (Suppl 1): S39-48.
8. Ramsay RE, Rowan AJ, Pryor FM (2004). Special considerations in treating the elderly patient with epilepsy. Neurology, 62 (Suppl 2): S24-9.
9. Hauser WA, Annegers JF, Kurland LT (1991). Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia, 32: 429-45.
10. Schachter SC, Cramer GW, Thompson GD, Chaponis RJ, Mendelson MA, Lawhorne L (1998). An evaluation of antiepileptic drug therapy in nursing facilities. J Am Geriatr Soc, 46: 1137-41.
11. Garrard J, Cloyd J, Gross C, Hardie N, Thomas L, Lackner T, Graves N, Leppik I (2000). Factors associated with antiepileptic drug use among elderly nursing home residents. J Gerontol A Biol Sci Med Sci, 55: M384-92.
12. Cloyd JC, Lackner TE, Leppik IE (1994). Antiepileptics in the elderly: pharmacepidemiology and pharmacokinetics. Arch Fam Med, 3: 589-98.
13. Lackner TE, Cloyd JC, Thomas LW, Leppik IE (1998). Antiepileptic drug use in nursing home residents: effect of age, gender and comedication on patterns of use. Epilepsia, 39: 1083-7.
14. Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, Spitz M, Frederick T, Towne A, Carter GS, Marks W, Felicetta J, Tomyanovich ML; VA Cooperative Study 428 Group (2005). New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology, 64: 1868-73.
15. Coeytaux A, Jallon P, Galobardes B, Morabia A (2000). Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology, 55: 693-7.
16. Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, Katsarou N, Hamer HM; Status Epilepticus Study Group Hessen (SESGH) (2001). Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia, 42: 714-8.
17. Wu YW, Shek DW, Garcia PA, Zhao S, Johnston SC (2002). Incidence and mortality of generalized convulsive status epilepticus in California. Neurology, 58: 1070-6.
18. Towne AR (2007). Epidemiology and outcomes of status epilepticus in the elderly. Int Rev Neurobiol, 81: 111-27.
19. Vignatelli L, Tonon C, D'Alessandro R; Bologna Group for the Study of Status Epilepticus (2003). Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia, 44: 964-8.
20. Garnett LK, Morton LD, Waterhouse EJ, Kernitsky L, Campbell ED, DeLorenzo RJ, Towne AR (2002). Bouncing back after status epilepticus: factors affecting functional outcome. Epilepsia, 43 (Suppl 7): S282-3.
21. So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP (1996). Population based study of seizure disorders after cerebral infarction. Neurology, 46: 350-5.
22. Hauser WA, Annegers JF, Rocca WA (1996). Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc, 71: 576-86.
23. Romanelli MF, Morris JC, Ashkin K, Coben LA (1990). Advanced Alzheimer's disease is a risk factor for lateonset seizures. Arch Neurol, 47: 847-50.
24. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA (1996). Dementia and adult onset unprovoked seizures. Neurology, 46: 727-30.
25. Aldenkamp AP, De Krom M, Reijs R (2003). Newer antiepileptic drugs and cognitive issues. Epilepsia, 44 (Suppl 4): 21-9.
26. Förstl H, Burns A, Levy R, Cairns N, Luthert P, Lantos P (1992). Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study. Arch Neurol, 49: 1038-42.
27. Spitz MC, Bainbridge JL, Winzenburg KV, Ramsay RE, Pryor FM, Uthman BM, Smith B, Edwards S, Johnson J, Wilson A, Stocco A, DVA CSP 428 Study Group (2003). Observations on the delay in diagnosis of seizures in the elderly: Update 3. Epilepsia, 44 (Suppl. 9): 18.
28. Ramsay RE, Rowan AJ, Pryor FM, Collins J, DVA CSP 428 Study Group (2000). Seizures in the older patient: demographics, diagnosis, and treatment. Epilepsia, 41 (Suppl 7): 172-3.
29. Ramsay RE, Rowan AJ, Slater JD, Collins J, Nemire R, Ortiz WR, VA Cooperative Study Group (1994). Effect of age on epilepsy and its treatment: results from the VA Cooperative study. Epilepsia, 35 (Suppl 8): 91.
30. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr (2005). Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia, 46: 470-2.
31. Stephen LJ, Brodie MJ (2000). Epilepsy in elderly people. Lancet, 355: 1441-46.
32. Arroyo S, Kramer G (2001). Treatment of epilepsy in the elderly: safety considerations. Drug Saf, 24: 991-1015.
33. McLean AJ, Le Couteur DG (2004). Aging biology and geriatric clinical pharmacology. Pharmacol Rev, 56: 163-184.
34. Baker GA, Jacoby A, Buck D, Brooks J, Potts P, Chadwick DW (2001). The quality of life of older people with epilepsy: findings from a UK community study. Seizure, 10: 92-9.
35. Rudzinski LA, Meador KJ (2011). Epilepsy: five new things. Neurology, 76(Suppl 2): S20-5.
36. Bernus I, Dickinson RG, Hooper WD, Eadie MJ (1997). Anticonvulsant therapy in aged patients: clinical pharmacokinetic considerations. Drugs Aging, 10: 278-89.
37. Perucca E, Berlowitz D, Birnbaum A, Cloyd JC, Garrard J, Hanlon JT, Levy RH, Pugh MJ (2006). Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Research, 68 (Suppl 1): S49-S63.
38. Brodie MJ, Overstall PW, Giorgi L (1999). Multicenter, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res, 37: 81-7.
39. Birnbaum A, Hardie NA, Leppik IE, Conway JM, Bowers SE, Lackner T, Graves NM (2003). Variability of total phenytoin serum concentrations within elderly nursing home residents. Neurology, 60: 555-9.
40. Birnbaum AK, Hardie NA, Conway JM, Bowers SE, Lackner TE, Graves NM, Leppik IE (2004). Valproic acid doses, concentrations, and clearances in elderly nursing home residents. Epilepsy Res, 62: 157-62.
41. Birnbaum AK, Conway JM, Hardie NA, Lackner TE, Bowers SE, Leppik IE (2007). Carbamazepine doseconcentration relationship in elderly nursing home residents. Epilepsy Res, 77: 31-5.
42. Ramsay RE, Uthman B, Pryor FM, Rowan AJ, Bainbridge J, Spitz M, Sirven JI, Frederick TE (2008). Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study. Epilepsia, 49: 1180-5.
43. Zeber JE, Copeland LA, Pugh MJ (2010). Variation in antiepileptic drug adherence among older patients with new-onset epilepsy. Ann Pharmacother, 44: 1896-904.
44. Kelly KM, Kharlamov A, Hentosz TM, Kharlamova EA, Williamson JM, Bertram EH 3rd, Kapur J, Armstrong DM (2001). Photothrombotic brain infarction results in seizure activity in aging Fischer 344 and Sprague Dawley rats. Epilepsy Res, 47: 189-203.
45. Kelly KM, Jukkola PI, Kharlamov EA, Downey KL, McBride JW, Strong R, Aronowski J (2006). Long-term video-EEG recordings following transient unilateral middle cerebral and common carotic artery occlusion in Long-Evans rats. Exp Neurol, 201: 495-506.
46. DiNapoli VA, Huber JD, Houser K, Li X, Rosen CL (2008). Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiol Aging, 5: 753-64.
47. Dinapoli VA, Benkovic SA, Li X, Kelly KA, Miller DB, Rosen CL, Huber JD, O'Callaghan JP (2010). Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat. Neuroscience, 170: 633-44.
48. Berges S, Moulin T, Berger E, Tatu L, Sablot D, Challier B, Rumbach L (2000). Seizures and epilepsy following strokes: recurrence factors. Eur Neurol, 43: 3-8.
49. Kharlamov EA, Jukkola PI, Schmitt KL, Kelly KM (2003). Electrobehavioral characteristics of epileptic rats following photothrombotic brain infarction. Epilepsy Res, 56: 185-203.
50. Karhunen H, Bezvenyuk Z, Nissinen J, Sivenius J, Jolkkonen J, Pitkänen A (2007). Epileptogenesis after cortical photothrombotic brain lesion in rats. Neuroscience, 148: 314-24.
51. Karhunen H, Pitkänen A, Virtanen T, Gureviciene I, Pussinen R, Ylinen A, Sivenius J, Nissinen J, Jolkkonen J (2003). Long-term functional consequences of transient occlusion of the middle cerebral artery in rats: a 1-year follow-up of the development of epileptogenesis and memory impairment in relation to sensorimotor deficits. Epilepsy Res, 54: 1-10.
52. Karhunen H, Nissinen J, Sivenius J, Jolkkonen J, Pitkänen A (2006). A long-term video-EEG and behavioral follow-up after endothelin-1 induced middle cerebral artery occlusion in rats. Epilepsy Res, 72: 25-38.
53. Jucker M (2010). The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med, 16: 1210-4.
54. Kelly KM (2002). Poststroke Seizures and Epilepsy: Clinical Studies and Animal Models. Epilepsy Curr, 2: 173-7.
55. Kelly KM (2007). Animal modeling of poststroke seizures and epilepsy: 5-year update. Epilepsy Curr, 7: 159-62.
56. Kelly KM (2010). Aging models of acute seizures and epilepsy. Epilepsy Curr, 10: 15-20.
57. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L (2007). Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron, 55: 697-711.
58. Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, Wu T, Hamto P, Devidze N, Yu GQ, Palop JJ, Noebels JL, Mucke L (2011). Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci, 31: 700-11.